Tularemia
diseaseOn this page
Also known as Deerfly feverFrancisella tularensis caused disease or disorderFrancisella tularensis disease or disorderFrancisella tularensis infectionFrancisella tularensis infectious diseaselemming feverOhara diseasePahvant Valley plaguerabbit feverYatobyo (Japan)
Summary
Tularemia (MONDO:0018077) is a disease (an umbrella term covering 6 Mondo subtypes) and 5 clinical trials. A subtype of primary bacterial infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 100 000 (Europe) [Orphanet-validated]
- Umbrella term: 6 Mondo subtypes
- Phenotypes (HPO): 38
- Clinical trials: 5
Clinical features
Epidemiology
Prevalence records
26 prevalence record(s), Orphanet, top 20 (validated / broadest geography first):
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.2 | Europe | Validated |
| Point prevalence | 1-9 / 100 000 | 2 | Europe | Validated |
| Annual incidence | <1 / 1 000 000 | United Kingdom | Validated | |
| Annual incidence | <1 / 1 000 000 | Netherlands | Validated | |
| Annual incidence | 1-9 / 100 000 | 4 | Sweden | Validated |
| Annual incidence | 1-9 / 100 000 | 1.27 | Czech Republic | Validated |
| Annual incidence | 1-9 / 100 000 | 9.1 | Finland | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.1 | Austria | Validated |
| Annual incidence | <1 / 1 000 000 | 0.005 | Belgium | Validated |
| Annual incidence | <1 / 1 000 000 | 0.05 | Denmark | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.3 | Croatia | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.6 | Bulgaria | Validated |
| Annual incidence | <1 / 1 000 000 | 0.075 | Estonia | Validated |
| Annual incidence | <1 / 1 000 000 | 0.08 | France | Validated |
| Annual incidence | <1 / 1 000 000 | 0.02 | Germany | Validated |
| Annual incidence | <1 / 1 000 000 | 0.035 | Italy | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.145 | Latvia | Validated |
| Annual incidence | <1 / 1 000 000 | 0.07 | Lithuania | Validated |
| Annual incidence | <1 / 1 000 000 | 0.01 | Poland | Validated |
| Annual incidence | <1 / 1 000 000 | 0.01 | Romania | Validated |
Signs & symptoms
Clinical features (HPO)
38 HPO clinical features (Orphanet curated; top 38 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001649 | Tachycardia | Frequent (30-79%) |
| HP:0001945 | Fever | Frequent (30-79%) |
| HP:0001974 | Leukocytosis | Frequent (30-79%) |
| HP:0002090 | Pneumonia | Frequent (30-79%) |
| HP:0002315 | Headache | Frequent (30-79%) |
| HP:0002829 | Arthralgia | Frequent (30-79%) |
| HP:0003326 | Myalgia | Frequent (30-79%) |
| HP:0010702 | Increased circulating antibody level | Frequent (30-79%) |
| HP:0025143 | Chills | Frequent (30-79%) |
| HP:0025406 | Asthenia | Frequent (30-79%) |
| HP:0000155 | Oral ulcer | Occasional (5-29%) |
| HP:0000988 | Skin rash | Occasional (5-29%) |
| HP:0001873 | Thrombocytopenia | Occasional (5-29%) |
| HP:0001903 | Anemia | Occasional (5-29%) |
| HP:0002098 | Respiratory distress | Occasional (5-29%) |
| HP:0002113 | Pulmonary infiltrates | Occasional (5-29%) |
| HP:0002202 | Pleural effusion | Occasional (5-29%) |
| HP:0002716 | Lymphadenopathy | Occasional (5-29%) |
| HP:0011355 | Localized skin lesion | Occasional (5-29%) |
| HP:0012735 | Cough | Occasional (5-29%) |
| HP:0025289 | Cervical lymphadenopathy | Occasional (5-29%) |
| HP:0025439 | Pharyngitis | Occasional (5-29%) |
| HP:0030833 | Neck pain | Occasional (5-29%) |
| HP:0031983 | Abnormal pulmonary thoracic imaging finding | Occasional (5-29%) |
| HP:0000388 | Otitis media | Very rare (<1-4%) |
| HP:0000509 | Conjunctivitis | Very rare (<1-4%) |
| HP:0000707 | Abnormality of the nervous system | Very rare (<1-4%) |
| HP:0000708 | Atypical behavior | Very rare (<1-4%) |
| HP:0001287 | Meningitis | Very rare (<1-4%) |
| HP:0001289 | Confusion | Very rare (<1-4%) |
| HP:0012219 | Erythema nodosum | Very rare (<1-4%) |
| HP:0030049 | Brain abscess | Very rare (<1-4%) |
| HP:0030953 | Conjunctival hyperemia | Very rare (<1-4%) |
| HP:0031292 | Cutaneous abscess | Very rare (<1-4%) |
| HP:0100533 | Inflammatory abnormality of the eye | Very rare (<1-4%) |
| HP:0100721 | Mediastinal lymphadenopathy | Very rare (<1-4%) |
| HP:0200026 | Ocular pain | Very rare (<1-4%) |
| HP:3000033 | Abnormality of nasopharyngeal adenoids | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | tularemia |
| Mondo ID | MONDO:0018077 |
| EFO | EFO:1001444 |
| MeSH | D014406 |
| Orphanet | 3392 |
| DOID | DOID:2123 |
| ICD-10-CM | A21 |
| NCIT | C85208 |
| SNOMED CT | 19265001 |
| UMLS | C0041351 |
| MedGen | 22520 |
| GARD | 0000396 |
| MedDRA | 10045146 |
| NORD | 1803 |
| Is cancer (heuristic) | no |
Also known as: Deerfly fever · Francisella tularensis caused disease or disorder · Francisella tularensis disease or disorder · Francisella tularensis infection · Francisella tularensis infectious disease · lemming fever · Ohara disease · Pahvant Valley plague · rabbit fever · Yatobyo (Japan)
Disease family
This is a subtype of primary bacterial infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › primary bacterial infectious disease › tularemia
Related subtypes (36): Buruli ulcer disease, sennetsu fever, salmonellosis, pinta disease, chancroid, gonorrhea, anthrax infection, leprosy, botulism, diphtheria, tetanus, bartonellosis, brucellosis, campylobacteriosis, glanders, granuloma inguinale, legionellosis, leptospirosis, listeriosis, Mycobacterium avium complex disease, ornithosis, rhinoscleroma, staphyloenterotoxemia, syphilis, cholera, ehrlichiosis, melioidosis, tuberculosis, plague, Q fever, shigellosis, Lyme disease, relapsing fever, spirillary rat-bite fever, streptobacillary rat-bite fever, Borrelia miyamotoi disease
Subtypes (6): glandular tularemia, typhoidal tularemia, ulceroglandular tularemia, oculoglandular tularemia, gastrointestinal tularemia, pneumonic tularemia
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 5.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE2 | 3 |
| Not specified | 2 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00584844 | PHASE2 | COMPLETED | Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine |
| NCT00787826 | PHASE2 | UNKNOWN | Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine |
| NCT03867162 | PHASE2 | WITHDRAWN | FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) |
| NCT06859619 | Not specified | NOT_YET_RECRUITING | Serological Measurement of Montpellier Professionals’ Contacts with Infectious Agents Responsible for Animal-borne Diseases |
| NCT05300425 | Not specified | COMPLETED | Seroprevalence of Leptospirosis in Val Müstair, Switzerland |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.